{"id":943526,"date":"2026-03-11T09:30:31","date_gmt":"2026-03-11T13:30:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/"},"modified":"2026-03-11T09:30:31","modified_gmt":"2026-03-11T13:30:31","slug":"agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/","title":{"rendered":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States"},"content":{"rendered":"

<\/p>\n

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States<\/b><\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–
\nAgilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company\u2019s expanding capabilities across Canada and the United States.<\/p>\n

\nAgilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing solutions.<\/p>\n

\nAgilent Advanced Therapeutics\u2019 CDMO portfolio includes oligonucleotides, microbial fermentation, complex and synthetic chemistry, bioreagents, highly potent APIs, and cell line development. The integrated platform provides customers streamlined access to end-to-end development and manufacturing services through a single partner \u2014 from discovery and process development through clinical- and commercial-scale manufacturing.<\/p>\n

\n\u201cThe Agilent Advanced Therapeutics solution strengthens our ability to support our customers and reinforces our long-term commitment to growth, investment, and leadership in this space,\u201d said Agilent President and CEO, Padraig McDonnell. \u201cFor our customers, this means a more integrated experience, deeper technical partnership and a trusted team that understands what it takes to bring life-changing therapies to patients.\u201d<\/p>\n

\nSimon May, president of Agilent\u2019s Life Sciences and Diagnostics Markets Group, added: \u201cThis launch reflects the combined excellence of our teams and our commitment to advancing the next generation of therapies. We are excited to bring our unified Agilent Advanced Therapeutics capabilities to partners around the world.\u201d<\/p>\n

\nAdditional details regarding Agilent Advanced Therapeutics are available on our website<\/a>.<\/p>\n

About Agilent Technologies<\/b><\/p>\n

\nAgilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent\u2019s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com<\/a>. To receive the latest Agilent news, subscribe to the Agilent Newsroom<\/a>. Follow Agilent on LinkedIn<\/a> and Facebook<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260311993066\/en\/<\/a><\/span><\/p>\n

INVESTOR CONTACT:
\n<\/b>
Tejas Savant
\n
+1 917-574-4018
\n
tejas.savant@agilent.com<\/a><\/p>\n

MEDIA CONTACT:
\n<\/b>
Kate Coyle
\n
+1 302-633-7490
\n
kate.coyle@agilent.com<\/a><\/p>\n

KEYWORDS:<\/b> California Colorado United States North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Technology Health Pharmaceutical Oncology Health Technology Medical Devices Research Software Genetics Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company\u2019s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing solutions. Agilent Advanced Therapeutics\u2019 CDMO portfolio includes oligonucleotides, microbial fermentation, complex and synthetic chemistry, bioreagents, highly potent APIs, and cell line development. The integrated platform provides customers streamlined access to end-to-end development and manufacturing services through a single partner \u2014 from discovery … <\/p>\n

Continue reading “Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-943526","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAgilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company\u2019s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing solutions. Agilent Advanced Therapeutics\u2019 CDMO portfolio includes oligonucleotides, microbial fermentation, complex and synthetic chemistry, bioreagents, highly potent APIs, and cell line development. The integrated platform provides customers streamlined access to end-to-end development and manufacturing services through a single partner \u2014 from discovery … Continue reading "Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-11T13:30:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States\",\"datePublished\":\"2026-03-11T13:30:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/\"},\"wordCount\":413,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/\",\"name\":\"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-03-11T13:30:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/","og_locale":"en_US","og_type":"article","og_title":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk","og_description":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company\u2019s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing solutions. Agilent Advanced Therapeutics\u2019 CDMO portfolio includes oligonucleotides, microbial fermentation, complex and synthetic chemistry, bioreagents, highly potent APIs, and cell line development. The integrated platform provides customers streamlined access to end-to-end development and manufacturing services through a single partner \u2014 from discovery … Continue reading \"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-11T13:30:31+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States","datePublished":"2026-03-11T13:30:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/"},"wordCount":413,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/","name":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-03-11T13:30:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260311993066r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-agilent-advanced-therapeutics-unifying-cdmo-capabilities-across-canada-and-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=943526"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943526\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=943526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=943526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=943526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}